Chronic Disease Flexible Coverage Act
- Bill Number
- H.R. 919
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Taxation
- Status
- Passed House
- Latest Action
- 2025-03-05: Received in the Senate and Read twice and referred to the Committee on Finance.
- Last Updated
- 2025-03-08T06:28:17Z
AI-Generated Summary
Purpose
The Chronic Disease Flexible Coverage Act (H.R. 919) aims to make permanent certain Internal Revenue Service (IRS) guidance that allows specific medical services and items for managing chronic conditions to be treated as "preventive care." This treatment applies to high-deductible health plans (HDHPs)—a type of health insurance with lower premiums but higher out-of-pocket costs before coverage kicks in—and health savings accounts (HSAs), which are tax-advantaged savings accounts for medical expenses.
Key Provisions
- Codification of IRS Guidance: The bill incorporates the details from IRS Notice 2019-45 into law, giving it the same legal weight as if it were directly written into the Internal Revenue Code (specifically, section 223(c)(2)(C), which defines what qualifies as preventive care for HDHPs and HSAs).
- Scope of Preventive Care: Under this guidance, certain services and items for chronic conditions (such as insulin for diabetes or low-dose aspirin for cardiovascular disease) can be provided without meeting the HDHP's deductible (the amount a person must pay out-of-pocket before insurance pays), as long as they are used for prevention or early detection.
- No Impact on Other Rules: The bill clarifies that it does not imply changes to any other IRS rules or future guidance on preventive services under the same tax code section.
Significant Changes to Existing Law
- Prior to this act, the treatment of chronic condition services as preventive care was based on IRS administrative guidance (Notice 2019-45), which could potentially be altered or revoked by the IRS without congressional action.
- This legislation converts that guidance into statutory law, providing permanence and protection against future administrative changes, ensuring consistent application unless Congress amends the law.
Potential Impacts
- On Citizens: Individuals with chronic conditions (e.g., diabetes, hypertension, or asthma) enrolled in HDHPs may gain easier access to essential medications and services without paying the full deductible upfront, potentially reducing out-of-pocket costs and encouraging better health management. This could make HDHPs more appealing to those with ongoing health needs.
- On Government Agencies: The IRS would have less flexibility to modify this specific guidance, shifting interpretive authority more firmly to Congress. It may reduce administrative workload by embedding the rule in the tax code.
- On International Relations: No direct impacts, as this is a domestic tax and health policy matter.
- Broader effects could include increased HSA usage and participation in HDHPs, potentially lowering overall healthcare spending through preventive focus, though it might slightly increase costs for insurers or employers offering these plans.
Main Stakeholders Affected
- Individuals with Chronic Conditions: Primary beneficiaries, as they can access covered services more affordably.
- HDHP Enrollees and HSA Users: All participants in these plans, including healthy individuals who might indirectly benefit from stabilized rules.
- Employers and Health Insurers: They offer HDHPs and must comply with the updated preventive care definitions, potentially affecting plan design and costs.
- IRS and Treasury Department: Responsible for enforcing tax code provisions related to HSAs.
- Healthcare Providers: May see increased demand for preventive services for chronic conditions without deductible barriers.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens taxpayer certainty by elevating IRS guidance to statutory status, reducing risks of legal challenges over administrative interpretations of tax benefits. It aligns with broader efforts to clarify HSA rules under the Affordable Care Act era.
- Constitutional: No direct challenges; it operates within Congress's established authority to regulate taxation and commerce (via the Taxing and Spending Clause).
- Political: Reflects bipartisan interest in expanding access to chronic care without raising premiums, potentially appealing to voters concerned with healthcare affordability. It could set a precedent for codifying other agency guidances into law to prevent regulatory shifts across administrations.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (2)
Rep. Panetta, Jimmy [D-CA-19], Rep. Tenney, Claudia [R-NY-24]
Recent Actions
- 2025-03-05: Received in the Senate and Read twice and referred to the Committee on Finance.
- 2025-03-04: Motion to reconsider laid on the table Agreed to without objection.
- 2025-03-04: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
- 2025-03-04: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
- 2025-03-04: DEBATE - The House proceeded with forty minutes of debate on H.R. 919.
- 2025-03-04: Considered under suspension of the rules. (consideration: CR H964-966)
- 2025-03-04: Mr. Smith (MO) moved to suspend the rules and pass the bill.
- 2025-02-04: Referred to the House Committee on Ways and Means.
- 2025-02-04: Introduced in House
- 2025-02-04: Introduced in House
Bill Versions
- Chronic Disease Flexible Coverage Act — issued 2025-03-04 — PDF (4 pages)
- Chronic Disease Flexible Coverage Act — issued 2025-02-04 — PDF (2 pages)
- Chronic Disease Flexible Coverage Act — issued 2025-03-05 — PDF (2 pages)